Skip to main content

FDA approves brentuximab vedotin for primary cutaneous anaplastic large cell lymphoma

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
FDA approves brentuximab vedotin for primary cutaneous anaplastic large cell lymphoma

User login

Username

Password

Reset your password

Type	Lead	score